Back to the main directory
EarningsReview / Equity
- Måsøval (Buy, TP: NOK37.00) - Q4 miss, positive 2024 guidance by DnB Markets
- NRC Group (Buy, TP: NOK15.00) - Q4 volume but not EBIT beat by DnB Markets
- Subsea 7 (Buy, TP: NOK200.00) - Minor model adjustments by DnB Markets
- Valuation update by DnB Markets
- Itaú BBA on Engie Brasil: In-Line 4Q23 Results by Itau
- Per Aarsleff - Strong cash flow increases payout potential by Danske Bank Equity Research
- Croda H223 results and 15 questions for management by BNP Paribas Exane
- Better Than Feared by BNP Paribas Exane
- Humming along… and, yes, panel pricing went up. by BNP Paribas Exane
- Ferrovial - Toll roads and FCF compensate 4Q23 miss in Construction by JB Capital Markets
- Value is in the eye of the beholder by BNP Paribas Exane
- Disappointing growth outlook - downgrade to Underperform by BNP Paribas Exane
- FQ4’24 postview: Growth still looking for a bottom by BNP Paribas Exane
- Zealand Pharma - Stepping on the gas pedal by Danske Bank Equity Research
- Gestamp - NAFTA disappoints but valuation remains attractive and restructuring plan is on the way; Buy by JB Capital Markets
- Results in-line, small TP reduction reflecting lower power prices by BNP Paribas Exane
- 理想汽车（LI US） by HSBC
- INVEST SECURITIES - TOOSLA : Redressement engagé, en avance sur les guidances - ACHAT, OC 2€ by Invest Securities
- Bilendi - Tendance à l’accélération confirmée by MidCap Partners
- INVEST SECURITIES - ORYZON GENOMICS : En ligne, premiers tirages d'OCA pour 10m€ à date - ACHAT, OC 4,8€ vs 6,6€ by Invest Securities
- REDEIA: RDOS. 2023 (ANÁLISIS BANCO SABADELL) by Sabadell
- Bilendi - Acceleration Trend Confirmed by MidCap Partners
- FERROVIAL: RDOS. 4T’23 (ANÁLISIS BANCO SABADELL) by Sabadell
- GLOBAL DOMINION: RDOS. 4T’23 (ANÁLISIS BANCO SABADELL) by Sabadell
- AMADEUS: RDOS. 4T’23 (ANÁLISIS BANCO SABADELL) by Sabadell
- Alvotech (Buy, TP: USD19.00) - Simlandi approved in the US by DnB Markets
- Oncopeptides (Hold, TP: SEK5.50) - US not an option, focus on Europe by DnB Markets
- SBB Norden (No_rec, TP: SEK) - Mixed Q4, more funding needed by DnB Markets
- Itaú BBA on Liverpool: Strong 4Q23 Results Beat Our and Consensus Expectations by Itau
- Itaú BBA on VTEX: Superb SSS Margins Give More Confidence in the LT Margin Algorithm; Guidance Not a Concern by Itau
- Jyske Bank - Buy/DKK 630: Buybacks are not far off – buy on weakness by Nordea
- Heads or tails? by BNP Paribas Exane
- BCP - Lowering 2024 COR on higher visibility for 2024; Buy by JB Capital Markets
- FQ4’24 postview: GenAI strategy taking shape and International improvements come through by BNP Paribas Exane
- Rovi - Increasing TP by 26% and upgrading to Buy on better CDMO perspectives and margins by JB Capital Markets
- Dear Rita-Rose, by BNP Paribas Exane
- Here we go again by BNP Paribas Exane
- Stranded (By) Overhead Costs by BNP Paribas Exane
- Semapa - Cement 4Q23 beats, lower DPS was partly expected; Buy by JB Capital Markets
- Jyske Bank - When no news is good news by Danske Bank Equity Research
- Li Auto (LI US) by HSBC
- CAF - Lower margins overshadow a strong FCF; reiterating Buy by JB Capital Markets
- Interparfums - Une profitabilité de plus en plus consistante by MidCap Partners
- INVEST SECURITIES - CROSSJECT : Financement sécurisé en attendant la barda - ACHAT, OC 6,0€ vs 6,3€ by Invest Securities
- In line numbers, waiting for better margin expansion by BNP Paribas Exane
- METROVACESA: RDOS. 2023 (ANÁLISIS BANCO SABADELL) by Sabadell
- Interparfums - Increasingly Consistent Profitability by MidCap Partners
- ENDESA: RDOS. 2023 (ANÁLISIS BANCO SABADELL) by Sabadell
- Pan American Silver - FY23 results: Follow the cash flow by Edison Investment Research
- AENA: RDOS. 2023 Y CAMBIO DE P.O. A BAJO REVISIÓN (ANÁLISIS BANCO SABADELL) by Sabadell